CONDENSED CONSOLIDATED STATEMENTS OF CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS' (DEFICIT) EQUITY - USD ($) $ in Thousands	Total	Common Stock	Additional Paid-In Capital	Accumulated Other Comprehensive (Loss) Income	Accumulated Deficit	Series A convertible preferred stock	Series B convertible preferred stock	Series C convertible preferred stock	Series D convertible preferred stock
Balance at Dec. 31, 2020	$ (54,781)	$ 1	$ 107,908	$ (1)	$ (162,689)
Balance, Shares at Dec. 31, 2020						57,758,734	12,500,000	37,528,581	31,740,554
Balance at Dec. 31, 2020						$ 16,176	$ 5,700	$ 16,759	$ 54,456
Balance, Shares at Dec. 31, 2020		521,052
Issuance of common stock upon exercise of stock options	17		17
Issuance of common stock upon exercise of stock options, Shares		3,773
Vesting of restricted common stock	4		4
Vesting of restricted common stock, Shares		10,202
Stock-based compensation expense	646		646
Issuance of Series D convertible preferred stock									$ 27,400
Issuance of Series D convertible preferred stock, Shares									15,870,209
Conversion of convertible preferred stock into common stock upon completion of initial public offering	120,491	$ 17	120,474
Conversion of convertible preferred stock into common stock upon completion of initial public offering, Shares						(57,758,734)	(12,500,000)	(37,528,581)	(47,610,763)
Conversion of convertible preferred stock into common stock upon completion of initial public offering						$ (16,176)	$ (5,700)	$ (16,759)	$ (81,856)
Conversion of convertible preferred stock into common stock upon completion of initial public offering, Shares		16,662,011
Issuance of common stock upon completion of initial public offering, net of commissions, underwriting discounts and offering costs	124,779	$ 7	124,772
Issuance of common stock upon completion of initial public offering, net of commissions, underwriting discounts and offering costs, Shares		7,662,000
Unrealized gain (loss) on available-for-sale securities	(20)			(20)
Net loss	(10,870)				(10,870)
Balance at Mar. 31, 2021	180,266	$ 25	353,821	(21)	(173,559)
Balance, Shares at Mar. 31, 2021		24,859,038
Balance at Dec. 31, 2020	(54,781)	$ 1	107,908	(1)	(162,689)
Balance, Shares at Dec. 31, 2020						57,758,734	12,500,000	37,528,581	31,740,554
Balance at Dec. 31, 2020						$ 16,176	$ 5,700	$ 16,759	$ 54,456
Balance, Shares at Dec. 31, 2020		521,052
Unrealized gain (loss) on available-for-sale securities	6
Net loss	(22,521)
Balance at Jun. 30, 2021	169,411	$ 25	354,591	5	(185,210)
Balance, Shares at Jun. 30, 2021		24,868,817
Balance at Mar. 31, 2021	180,266	$ 25	353,821	(21)	(173,559)
Balance, Shares at Mar. 31, 2021		24,859,038
Issuance of common stock upon exercise of stock options	1		1
Issuance of common stock upon exercise of stock options, Shares		354
Vesting of restricted common stock	5		5
Vesting of restricted common stock, Shares		9,425
Stock-based compensation expense	764		764
Unrealized gain (loss) on available-for-sale securities	26			26
Net loss	(11,651)				(11,651)
Balance at Jun. 30, 2021	169,411	$ 25	354,591	5	(185,210)
Balance, Shares at Jun. 30, 2021		24,868,817
Balance at Dec. 31, 2021	141,689	$ 25	356,308	(132)	(214,512)
Balance, Shares at Dec. 31, 2021		24,951,983
Vesting of restricted common stock, Shares		4,573
Stock-based compensation expense	842		842
Unrealized gain (loss) on available-for-sale securities	(395)			(395)
Net loss	(14,016)				(14,016)
Balance at Mar. 31, 2022	128,120	$ 25	357,150	(527)	(228,528)
Balance, Shares at Mar. 31, 2022		24,956,556
Balance at Dec. 31, 2021	$ 141,689	$ 25	356,308	(132)	(214,512)
Balance, Shares at Dec. 31, 2021		24,951,983
Conversion of convertible preferred stock into common stock upon completion of initial public offering, Shares	16,662,011
Unrealized gain (loss) on available-for-sale securities	$ (456)
Net loss	(31,062)
Balance at Jun. 30, 2022	$ 111,858	$ 25	357,995	(588)	(245,574)
Balance, Shares at Jun. 30, 2022	0
Balance, Shares at Jun. 30, 2022		24,959,848
Balance at Mar. 31, 2022	$ 128,120	$ 25	357,150	(527)	(228,528)
Balance, Shares at Mar. 31, 2022		24,956,556
Vesting of restricted common stock, Shares		3,292
Stock-based compensation expense	845		845
Unrealized gain (loss) on available-for-sale securities	(61)			(61)
Net loss	(17,046)				(17,046)
Balance at Jun. 30, 2022	$ 111,858	$ 25	$ 357,995	$ (588)	$ (245,574)
Balance, Shares at Jun. 30, 2022	0
Balance, Shares at Jun. 30, 2022		24,959,848